Canlyniadau Chwilio - Lièvre, Astrid

Patient healthcare trajectories of intrahepatic cholangiocarcinoma in France: A nationwide retrospective analysis gan Neuzillet, Cindy, Emery, Corinne, Teissier, Clément, Bouée, Stéphane, Lièvre, Astrid

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Brain metastases from pancreatic adenocarcinoma gan Zaanan, Aziz, Lequoy, Marie, Landi, Bruno, Lievre, Astrid, Franco, Dominique, Taïeb, Julien

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Significant decrease in interval colorectal cancer incidence after implementing immunochemical testing in a multiple-round guaiac-based screening programme gan Bretagne, Jean-François, Carlo, Aurore, Piette, Christine, Rousseau, Chloé, Cosson, Mathilde, Lièvre, Astrid

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Is the gene encoding Chibby implicated as a tumour suppressor in colorectal cancer ? gan Gad, Sophie, Teboul, David, Lièvre, Astrid, Goasguen, Nicolas, Berger, Anne, Beaune, Philippe, Laurent-Puig, Pierre

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Incidental colorectal focal (18) F-FDG uptake: a novel indication for colonoscopy gan Rigault, Eugénie, Lenoir, Laurence, Bouguen, Guillaume, Pagenault, Mael, Lièvre, Astrid, Garin, Etienne, Siproudhis, Laurent, Bretagne, Jean-François

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Prognostic value of serum CYFRA 21-1 1 in patients with anal canal squamous cell carcinoma treated with radio(chemo)therapy gan Gauthé, Mathieu, Richard-Molard, Marion, Rigault, Eugénie, Buecher, Bruno, Mariani, Pascale, Bellet, Dominique, Cacheux, Wulfran, Lièvre, Astrid

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Multidisciplinary team meetings: are all patients presented and does it impact quality of care and survival – a registry-based study gan Rollet, Quentin, Bouvier, Véronique, Moutel, Grégoire, Launay, Ludivine, Bignon, Anne-Laure, Bouhier-Leporrier, Karine, Launoy, Guy, Lièvre, Astrid

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Bevacizumab plus FOLFIRI or FOLFOX in chemotherapy-refractory patients with metastatic colorectal cancer: a retrospective study gan Lièvre, Astrid, Samalin, Emmanuelle, Mitry, Emmanuel, Assenat, Eric, Boyer-Gestin, Christine, Lepère, Céline, Bachet, Jean-Baptiste, Portales, Fabienne, Vaillant, Jean-Nicolas, Ychou, Marc, Rougier, Philippe

Cael y testun llawn Cael y testun llawn Cael y testun llawn

FOLFIRINOX De‐Escalation in Advanced Pancreatic Cancer: A Multicenter Real‐Life Study gan Chevalier, Hortense, Vienot, Angélique, Lièvre, Astrid, Edeline, Julien, El Hajbi, Farid, Peugniez, Charlotte, Vernerey, Dewi, Meurisse, Aurélia, Hammel, Pascal, Neuzillet, Cindy, Borg, Christophe, Turpin, Anthony

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Incidental anal (18)fluorodeoxyglucose uptake: Should we further examine the patient? gan Moussaddaq, Anne-Sophie, Brochard, Charlène, Palard-Novello, Xavier, Garin, Etienne, Wallenhorst, Timothée, Le Balc’h, Eric, Merlini L’heritier, Alexandre, Grainville, Thomas, Siproudhis, Laurent, Lièvre, Astrid

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Management of digestive cancers during the COVID-19 second wave: A French intergroup point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR) gan Tougeron, David, Michel, Pierre, Lièvre, Astrid, Ducreux, Michel, Gaujoux, Sébastien, Guiu, Boris, Huguet, Florence, Lecomte, Thierry, Lepage, Côme, Louvet, Christophe, Maggiori, Léon, Mariani, Pascale, Aparicio, Thomas, Bouché, Olivier

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma gan Lièvre, Astrid, Ouine, Bérèngere, Canet, Jim, Cartier, Aurélie, Amar, Yael, Cacheux, Wulfran, Mariani, Odette, Guimbaud, Rosine, Selves, Janick, Lecomte, Thierry, Guyetant, Serge, Bieche, Ivan, Berger, Frédérique, de Koning, Leanne

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Correction: Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma gan Lièvre, Astrid, Ouine, Bérèngere, Canet, Jim, Cartier, Aurélie, Amar, Yael, Cacheux, Wulfran, Mariani, Odette, Guimbaud, Rosine, Selves, Janick, Lecomte, Thierry, Guyetant, Serge, Bieche, Ivan, Berger, Frédérique, de Koning, Leanne

Cael y testun llawn Cael y testun llawn Cael y testun llawn

FOLFIRINOX relative dose intensity and disease control in advanced pancreatic adenocarcinoma gan Vary, Antonin, Lebellec, Loïc, Di Fiore, Frédéric, Penel, Nicolas, Cheymol, Claire, Rad, Emilia, El Hajbi, Farid, Lièvre, Astrid, Edeline, Julien, Bimbai, André Michel, Le Deley, Marie-Cécile, Turpin, Anthony

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Genetic polymorphisms of MMP1, MMP3 and MMP7 gene promoter and risk of colorectal adenoma gan Lièvre, Astrid, Milet, Jacqueline, Carayol, Jérôme, Le Corre, Delphine, Milan, Chantal, Pariente, Alexandre, Nalet, Bernard, Lafon, Jacques, Faivre, Jean, Bonithon-Kopp, Claire, Olschwang, Sylviane, Bonaiti-Pellié, Catherine, Laurent-Puig, Pierre

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Correction to: Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study gan Zaibet, Sonia, Hautefeuille, Vincent, Auclin, Edouard, Lièvre, Astrid, Tougeron, David, Sarabi, Mathieu, Gilabert, Marine, Wasselin, Julie, Edeline, Julien, Artru, Pascal, Bechade, Dominique, Morin, Clémence, Ducoulombier, Agnes, Taieb, Julien, Pernot, Simon

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Gemcitabine + Nab-paclitaxel or Gemcitabine alone after FOLFIRINOX failure in patients with metastatic pancreatic adenocarcinoma: a real-world AGEO study gan Zaibet, Sonia, Hautefeuille, Vincent, Auclin, Edouard, Lièvre, Astrid, Tougeron, David, Sarabi, Mathieu, Gilabert, Marine, Wasselin, Julie, Edeline, Julien, Artru, Pascal, Bechade, Dominique, Morin, Clémence, Ducoulombier, Agnes, Taieb, Julien, Pernot, Simon

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Prognostic factors of BRAF V600E colorectal cancer with liver metastases: a retrospective multicentric study gan Javed, Sahir, Benoist, Stéphane, Devos, Patrick, Truant, Stéphanie, Guimbaud, Rosine, Lièvre, Astrid, Sefrioui, David, Cohen, Romain, Artru, Pascal, Dupré, Aurélien, Bachet, Jean-Baptiste, de la Fouchardière, Christelle, Ploquin, Anne, Turpin, Anthony

Cael y testun llawn Cael y testun llawn Cael y testun llawn

COVID-19 epidemic: Proposed alternatives in the management of digestive cancers: A French intergroup clinical point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR) gan Di Fiore, Frederic, Bouché, Olivier, Lepage, Come, Sefrioui, David, Gangloff, Alice, Schwarz, Lilian, Tuech, Jean Jacques, Aparicio, Thomas, Lecomte, Thierry, Boulagnon-Rombi, Camille, Lièvre, Astrid, Manfredi, Sylvain, Phelip, Jean Marc, Michel, Pierre

Cael y testun llawn Cael y testun llawn Cael y testun llawn

Radioembolization Plus Chemotherapy for First-line Treatment of Locally Advanced Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial gan Edeline, Julien, Touchefeu, Yann, Guiu, Boris, Farge, Olivier, Tougeron, David, Baumgaertner, Isabelle, Ayav, Ahmet, Campillo-Gimenez, Boris, Beuzit, Luc, Pracht, Marc, Lièvre, Astrid, Le Sourd, Samuel, Boudjema, Karim, Rolland, Yan, Boucher, Eveline, Garin, Etienne

Cael y testun llawn Cael y testun llawn Cael y testun llawn